New GLORY-2 Results Highlight Mazdutide’s Potential in Obesity Management Innovent Biologics, in collaboration with partner companies, announced encouraging results from the GLORY-2 study evaluating Mazdutide 9 mg in Chinese adults with obesity. The multi-center trial reports substantial weight loss and favorable safety signals, with reductions reaching as high as 20.1% of baseline body weight for…